SEC Form 5 · accession 0001567619-19-003861
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean Jacques Bienaime
Officer — Chief Executive Officer · Director
Period of report
Dec 31, 2018
Accepted (ET)
Feb 13, 2019 · 6:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 1, 2018 | G | 160 | $0.00 | D | 181,341 | I | Shares held by Jean-Jacques Bienaime Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On May 1, 2018 the reporting person gifted 160 shares to an educational institution.